Keryx Biopharmaceuticals Inc fka KERX

[Er0ck]

lol wheres the "defense".... All it says is "bulter begs to differ" but then doesn't go into any details about how he differs or what he is using to support his difference in opinion.

Hard to ignore the facts, things not looking good here.

"Keryx Pharmaceuticals (KERX_) shares fell 22% to $7.11 Friday after an independent research firm raised questions about the company's ability to convince FDA to grant New Chemical Entity status to its experimental iron-based phosphate binder Zerenex.

IPD Analytics, which conducts intellectual property healthcare research for Wall Street investors, issued its Keryx report on Friday. The IPD report also questioned the strength of Keryx's patents protecting Zerenex from potential generic competitors."